Inventor · disambiguated record
Nils Lonberg
Also filed as: LONBERG NILS
67 granted patents·34 pending applications·38,296 citations·filing 1987–2025
99Inventor score
Top patents by PatentIndex Score
101 records- 0199US9505839B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 29, 2016·123 cites·16 claims
- 0299US8017114B2Human CTLA-4 antibodies and their usesMEDAREX INC·Filed 2009·Granted Sep 13, 2011·199 cites·33 claims
- 0399US7605238B2Human CTLA-4 antibodies and their usesMEDAREX INC·Filed 2001·Granted Oct 20, 2009·353 cites·32 claims
- 0499US7501552B2Transgenic non-human animals for producing chimeric antibodiesMEDAREX INC·Filed 2004·Granted Mar 10, 2009·182 cites·3 claims
- 0599US7041871B1Transgenic non-human animals capable of producing heterologous antibodiesGENPHARM INT·Filed 2000·Granted May 9, 2006·93 cites·14 claims
- 0699US7041870B2Transgenic transchromosomal rodents for making human antibodiesKIRIN BREWERY·Filed 2001·Granted May 9, 2006·822 cites·4 claims
- 0799US6984720B1Human CTLA-4 antibodiesMEDAREX INC·Filed 2000·Granted Jan 10, 2006·897 cites·14 claims
- 0899US5877397ATransgenic non-human animals capable of producing heterologous antibodies of various isotypesGENPHARM INT·Filed 1994·Granted Mar 2, 1999·1.6k cites·10 claims
- 0999US5874299ATransgenic non-human animals capable of producing heterologous antibodiesGENPHARM INT·Filed 1997·Granted Feb 23, 1999·1.1k cites·7 claims
- 1099US5814318ATransgenic non-human animals for producing heterologous antibodiesGENPHARM INT·Filed 1993·Granted Sep 29, 1998·2k cites·10 claims
- 1199US5789650ATransgenic non-human animals for producing heterologous antibodiesGENPHARM INT·Filed 1992·Granted Aug 4, 1998·1.5k cites·5 claims
- 1299US5770429ATransgenic non-human animals capable of producing heterologous antibodiesGENPHARM INT·Filed 1995·Granted Jun 23, 1998·2.7k cites·16 claims
- 1399US5661016ATransgenic non-human animals capable of producing heterologous antibodies of various isotypesGENPHARM INT·Filed 1993·Granted Aug 26, 1997·4.2k cites·21 claims
- 1499US5633425ATransgenic non-human animals capable of producing heterologous antibodiesGENPHARM INT·Filed 1992·Granted May 27, 1997·4.4k cites·7 claims
- 1599US5625126ATransgenic non-human animals for producing heterologous antibodiesGENPHARM INT·Filed 1994·Granted Apr 29, 1997·4.3k cites·5 claims
- 1699US5569825ATransgenic non-human animals capable of producing heterologous antibodies of various isotypesGENPHARM INT·Filed 1991·Granted Oct 29, 1996·4.7k cites·8 claims
- 1799US5545806ARansgenic non-human animals for producing heterologous antibodiesGENPHARM INT·Filed 1992·Granted Aug 13, 1996·5.5k cites·14 claims
- 1899US4873316AIsolation of exogenous recombinant proteins from the milk of transgenic mammalsBIOGEN INC·Filed 1987·Granted Oct 10, 1989·1.3k cites·3 claims
- 1998US10377824B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 13, 2019·19 cites·30 claims
- 2098US10266591B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 23, 2019·20 cites·37 claims
- 2198US9228016B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 5, 2016·85 cites·19 claims
- 2298US8784815B2Human CTLA-4 antibodies and their usesKORMAN ALAN J·Filed 2012·Granted Jul 22, 2014·40 cites·29 claims
- 2398US8318916B2Human CTLA-4 antibodies and their usesKORMAN ALAN J·Filed 2011·Granted Nov 27, 2012·49 cites·38 claims
- 2498US8158419B2Transgenic non-human animals for producing chimeric antibodiesLONBERG NILS·Filed 2008·Granted Apr 17, 2012·93 cites·2 claims
- 2598US6300129B1Transgenic non-human animals for producing heterologous antibodiesGENPHARM INTERNAT·Filed 1996·Granted Oct 9, 2001·365 cites·4 claims
- 2698US6255458B1High affinity human antibodies and human antibodies against digoxinGENPHARM INTERNAT·Filed 1998·Granted Jul 3, 2001·515 cites·2 claims
- 2798US5750172ATransgenic non human mammal milkPHARMING BV·Filed 1995·Granted May 12, 1998·340 cites·5 claims
- 2897US10501550B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 10, 2019·9 cites·58 claims
- 2997US10465010B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 5, 2019·9 cites·15 claims
- 3097US9745379B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 29, 2017·11 cites·58 claims
- 3197US9605080B2Antibodies against CD73BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 28, 2017·31 cites·30 claims
- 3296US11274152B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 15, 2022·6 cites·12 claims
- 3396US10100129B2Antibodies against CD73 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 16, 2018·24 cites·35 claims
- 3495US7722873B2Heterologous antibodies which bind human CD4GENPHARM INT·Filed 2006·Granted May 25, 2010·36 cites·14 claims
- 3595US7135287B1Human antibodiesMEDAREX INC·Filed 2000·Granted Nov 14, 2006·62 cites·12 claims
- 3694US11345752B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 31, 2022·4 cites·36 claims
- 3794US11084881B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 10, 2021·3 cites·19 claims
- 3893US12173081B2CD19/CD38 multispecific antibodiesBIOGRAPH 55 INC·Filed 2024·Granted Dec 24, 2024·4 cites·13 claims
- 3993US12049503B2Treatment of LAG-3 positive tumorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 30, 2024·4 cites·30 claims
- 4093US11299551B2Composite binding molecules targeting immunosuppressive B cellsBIOGRAPH 55 INC·Filed 2021·Granted Apr 12, 2022·6 cites·17 claims
- 4193US11213586B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 4, 2022·5 cites·14 claims
- 4293US10081681B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 25, 2018·17 cites·18 claims
- 4393US7816578B2Transgenic transchromosomal rodents for making human antibodiesKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Oct 19, 2010·11 cites·7 claims
- 4493US7084260B1High affinity human antibodies and human antibodies against human antigensGENPHARM INT·Filed 1996·Granted Aug 1, 2006·96 cites·7 claims
- 4592US10690674B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·5 cites·27 claims
- 4692US8664407B2Chemical linkers with single amino acids and conjugates thereofCHEN LIANG·Filed 2008·Granted Mar 4, 2014·26 cites·7 claims
- 4791US10653791B2Antibodies comprising modified heavy constant regionsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 19, 2020·10 cites·6 claims
- 4891US6794132B2Human antibodiesBIOSITE INC·Filed 1999·Granted Sep 21, 2004·92 cites·34 claims
- 4991US2025136684A1Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 5090US11807686B2Treatment of LAG-3 positive tumorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 7, 2023·5 cites·38 claims
Showing the top 50 of 101 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nils Lonberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →